Laura Sekirov

Treating Diabetes and Obesity with an FGF21-Mimetic Antibody Activating the βKlotho/FGFR1c Receptor Complex

Ian N. Foltz, Sylvia Hu, Chadwick King et al. · Science Translational Medicine · 2012 · 211 citations

Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN

Susan de Jong, Ghania Chikh, Laura Sekirov et al. · Cancer Immunology Immunotherapy · 2007 · 132 citations · Full text

Nanoparticles, Nanomedicine, Cpg Odn +11

Stabilized plasmid-lipid particles for regional gene therapy: formulation and transfection properties

Y P Zhang, Laura Sekirov, Edward G. Saravolac et al. · Gene Therapy · 1999 · 109 citations

Cell-based Drug Delivery, Nanomedicine, Lipid Preparation +12

Asymmetrical Fc Engineering Greatly Enhances Antibody-dependent Cellular Cytotoxicity (ADCC) Effector Function and Stability of the Modified Antibodies

Zhi Liu, Kannan Gunasekaran, Wei Wang et al. · Journal of Biological Chemistry · 2013 · 72 citations · Full text

Medicine, Effector Function, Immunoengineering +10

Effects of intravenous and subcutaneous administration on the pharmacokinetics, biodistribution, cellular uptake and immunostimulatory activity of CpG ODN encapsulated in liposomal nanoparticles

Kaley D. Wilson, Sam G. Raney, Laura Sekirov et al. · International Immunopharmacology · 2007 · 67 citations

Cpg Odn, Nanomedicine, Cell-based Drug Delivery +7